Is there a vaccine against RSV? After nearly 60 years, many potential candidates came at the same time

Published Date: 02 Mar 2023

You may not have heard of respiratory syncytial virus (RSV). However, it killed more than 100,000 people worldwide in 2019, making it the leading cause of death among children under the age of one.

Read Full News

Latest News

Immigrant Docs at Center of Storm as Court Battles Intensify

Rapid changes to federal immigration policy including travel bans mean uncertain futures for many immigrant physicians and medical students hoping to enter or remain in the US.

Health Workers Struggle to Contain Ebola in Congo Camps as Distrust Grows

After the Kpangba displacement camp became the first in this part of war-torn Congo to record deaths from Ebola two weeks ago, health ⁠workers rushed to trace those who had...

New Score May Improve Pediatric Anaphylaxis Care

A new risk score stratifies children’s risk for biphasic anaphylaxis and could reduce unnecessary emergency department observation for most patients.

Jazz Pharmaceuticals Lung Cancer Drug Fails Main Trial Goal

Jazz Pharmaceuticals said on Friday its lung cancer drug Zepzelca failed to meet the main goal ⁠of improving overall survival in a late-stage study, potentially risking its...

SAT Offers Hope for Prosthetic Vascular Graft Infection Care

Suppressive antimicrobial therapy is a viable option for patients with prosthetic vascular graft infection who are at a high surgical risk.

Four JAK Inhibitors Have Positive Late-Stage Trial Results

Data from phase 3 studies with filgotinib, gecacitinib, and ivarmacitinib and a phase 4 study of tofacitinib in early disease are reported.

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Latest News

Rapid changes to federal immigration policy including travel bans mean uncertain futures for many immigrant physicians and medical students hoping to enter or remain in the US.

After the Kpangba displacement camp became the first in this part of war-torn Congo to record deaths from Ebola two weeks ago, health ⁠workers rushed to trace those who had...

A new risk score stratifies children’s risk for biphasic anaphylaxis and could reduce unnecessary emergency department observation for most patients.

Jazz Pharmaceuticals said on Friday its lung cancer drug Zepzelca failed to meet the main goal ⁠of improving overall survival in a late-stage study, potentially risking its...

Suppressive antimicrobial therapy is a viable option for patients with prosthetic vascular graft infection who are at a high surgical risk.

Data from phase 3 studies with filgotinib, gecacitinib, and ivarmacitinib and a phase 4 study of tofacitinib in early disease are reported.

News All Time

Latin America’s HIV Mortality Gap: Can Research Close It?

Latin America continues to lag the global decline in HIV-related mortality, prompting experts to identify research priorities targeting advanced HIV and gaps in care.

A Cracked Coffin, a Funeral and the Hunt for Ebola's Patient Zero

By the time the truck pulled away from the morgue in Bunia, the morning heat hung heavily over the road to Mongbwalu.

Two Babies From Congo Orphanage Die Of Ebola, Highlighting Risk to Children

After her mother died in late May, baby Buswaza was brought to a church-run orphanage in eastern Congo where the nuns quickly discovered the newborn was running a...

The Cost of Complacency: Measles on the Rise in Canada

The current outbreak has demonstrated the effectiveness of vaccination, and physicians play a crucial role in rebuilding confidence in vaccines.

Deep Dive: When Hitting the LDL Target Isn't Enough

The case for lowering LDL-C is strong. It is not, however, the whole story.

C difficile Hospital Deaths Rose in the COVID Pandemic

Clostridioides difficile infection, especially complicated by COVID, elevates nosocomial mortality risk in the US, whereas admissions decrease.

US Doctor Isolated in Czech Hospital for Ebola Monitoring Released, Heading Home

A U.S. doctor who was transferred to a Czech hospital from ⁠Uganda last month as a precaution after having contact with a patient with ⁠Ebola has been released and is on his...

CCL19 as a Biomarker May Track IgG4-Related Disease Activity

CCL19 emerges as a promising biomarker that distinguishes active disease from treatment-induced remission and may help to identify relapsing disease in patients with IgG4-related disease.

Randomized Trial Supports Sirolimus as Add-On Lupus Therapy

Sirolimus given in addition to standard therapy for active uncontrolled systemic lupus erythematosus may offer another therapeutic option, randomized trial findings suggest.

Trajectory to RA Diagnosis Differs According to ACPA Status

Patients with anti-citrullinated protein antibodies may present later but experience progression to RA faster and show different disease features than those without these antibodies.

Several Markers May Flag Severity of Peanut Allergy in Kids

Several biomarker measures such as wheal diameters on skin prick tests, peanut-specific antibody levels, and basophil activation differ between children with severe vs mild reactions to peanuts.

Visible Light and Skin Health: What Clinicians Should Know

An international expert panel issues consensus recommendations on visible light photoprotection, highlighting its emerging role in skin health and disease.

Race-Neutral Data Show Biologics’ Benefits for Kids’ Asthma

Lung function shows improvement using GLI global reference equations.

MHRA Approves Nipocalimab for Myasthenia Gravis

The MHRA has authorised nipocalimab for generalised myasthenia gravis in adults and adolescents aged 12 and over, based on evidence from two clinical studies.

WHO's Tedros Says Uganda Should Reconsider Congo Border Closure Over Ebola

The director-general of the World Health Organization said on Monday ⁠that Uganda should reconsider its decision to close its border with Democratic ⁠Republic of Congo...

AI Brings Oxygen Therapy Closer to Autopilot

EMILY.AI uses AI to personalize oxygen delivery in real time, aiming for safer saturation control and fewer manual adjustments.

Recommended News For You

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

Alkem introduces cetuximab under the trade name Cetuxa in India.

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

Rising rates of head and neck cancers in England

Recommended Articles For You

Cancer Vaccines In India: The Latest Hope In The Fight Against Disease 

Understanding Neutrophilia: Causes, Symptoms, and Treatment Options 

Unleashing the Power of Immune Triads: A Novel Approach to Cancer Immunotherapy 

Hope for a Cure: Exploring New Treatments for Sickle Cell Anemia 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A pilot study investigates a novel strategy for lowering anxiety and enhancing post-stem cell transplant quality of life.

2.

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC

3.

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

4.

Rural residents continue to have higher odds of skin cancer, study finds

5.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

1.

Understanding Extramammary Paget's Disease: Causes, Symptoms and Treatment Options

2.

Comprehensive Updates in Hematology and Quality Improvement

3.

Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts

4.

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments

5.

Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

2.

Efficient Management of First line ALK-rearranged NSCLC

3.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

5.

Navigating the Complexities of Ph Negative ALL - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot